[1]BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263.
[2]HEIMBAC JK,KULIK LM,FINN RS,et al.AASLD guidelines for the treatment of hepatocellular carcinoma[J].Hepatology,2018,67(1):358-380.
[3]王维虎,曾昭冲.中国原发性肝细胞癌放射治疗指南(2020年版)[J].临床肝胆病杂志,2021,37(5):1029-1033.
WANG WH,ZENG SC.Chinese radiotherapy guidelines for primary hepatocellular carcinoma(2020 edition)[J].Journal of Clinical Hepatology,2021,37(5):1029-1033.
[4]中华人民共和国国家卫生健康委员会.原发性肝癌诊疗指南(2022年版)[J].肿瘤综合治疗电子杂志,2022,8(02):16-53.
National Health Commission of the People's Republic of China.Standardization for diagnosis and treatment of primary hepatic carcinoma(2022 edition)[J].Journal of Multidisciplinary Cancer,2022,8(02):16-53.
[5]KATZ AW,WINTER KA,DAWSON LA,et al.RTOG 0438:A phase I trial of highly conformal radiation therapy for patients with liver metastases[J].Journal of Clinical Oncology,2012,30(4_suppl):257.
[6]ZHOU M,WANG H,ZENG X,et al.Mortality,morbidity,and risk factors in China and its provinces,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet(London,England),2019,394(10204):1145-1158.
[7]SEBASTIANN T,XU-WELLIVER M,WILLIAMS TM.Stereotactic body radiation therapy(SBRT) for early stage nonsmall cell lung cancer(NSCLC):contemporary insights and advances[J].Journal of Thoracic Disease,2018,10(S21):S2451-S2464.
[8]TIMMERMAN RD,KAVANAGH BD,CHO LC,et al.Stereotactic body radiation therapy in multiple organ sites[J].Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology,2007,25(8):947-952.
[9]SU TS,LIANG P,LIANG J,et al.Long-term survival analysis of stereotactic ablative radiotherapy versus liver resection for small hepatocellular carcinoma[J].Int J Radiat Oncol Biol Phys,2017,98(3):639-646.
[10]KOOM WS,SEONG J,HAN KH,et al.Is local radiotherapy still valuable for patients with multiple intrahepatic hepatocellular carcinomas[J].Int J Radiat Oncol Biol Phys,2010,77(5):1433-1440.
[11]YAPARPALVI R,GARG MK,SHEN J,et al.Evaluating which plan quality metrics are appropriate for use in lung SBRT[J].The British Journal of Radiology,2018,91(1083):0170393.
[12]LEASURE JM,ULIZIO V,PEARSON D.Retrospective dosimetric analysis of brain lesions planned in Pinnacle 9.8 via a HDMLC linac[J].Medical Dosimetry,2019,44(3):e8-e12.
[13]VIDETIC GM,HU C,SINGH A,et al.Radiation therapy oncology group(RTOG) protocol 0915:A randomized phase 2 study comparing 2 stereotactic body radiation therapy(SBRT) schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer[J].International Journal of Radiation Oncology Biology Physics,2013,87(2):S3.
[14]BEZJAK A.Seamless phase I/II study of stereotactic lung radiotherapy(SBRT) for early stage,centrally located,non-small cell lung cancer(NSCLC) in medically inoperable patients[J].RTOG,2012,813:1-75.
[15]CHEN YX,ZHUANG Y,YANG P,et al.Helical IMRT-based stereotactic body radiation therapy using an abdominal compression technique and modified fractionation regimen for small hepatocellular carcinoma[J].Technology in Cancer Research & Treatment,2020,19(3):153303382093700.
[16]PADDICK I,LIPPITZ B.A simple dose gradient measurement tool to complement the conformity index[J].Journal of Neurosurgery,2006,105:194-201.
[17]HODAPP N.The ICRU report 83:prescribing,recording and reporting photon-beam intensity-modulated radiation therapy(IMRT)[J].Strahlentherapie und Onkologie,2012,188(1):97-99.
[18]HURKMANS CW,CUIJPERS JP,LAGERWAARD FJ,et al.Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer:report from the Quality Assurance Working Party of the randomised phase Ⅲ ROSEL study[J].Radiation Oncology,2009,4(1):1-14.
[19]KYOUNGJUN Y,JUNGWON K,BYUNGCHUL C,et al.Gated volumetric-modulated arc therapy vs tumor-tracking cyberknife radiotherapy as stereotactic body radiotherapy for hepatocellular carcinoma:A dosimetric comparison study focused on the impact of respiratory motion managements[J].PLoS One,2016,11(11):e0166927.
[20]PAIK EK,KIM MS,CHOI CW,et al.Dosimetric comparison of volumetric modulated arc therapy with robotic stereotactic radiation therapy in hepatocellular carcinoma[J].Radiation Oncology Journal,2015,33(3):233-241.
[21]LEE J,DEAN C,PATEL R,et al.Multi-center evaluation of dose conformity in stereotactic body radiotherapy[J].Phys Imaging Radiat Oncol,2019,11:41-46.